Nora Sandorfi, MD
Professor of Clinical Medicine (Rheumatology)
Department: Medicine
Contact information
3400 Spruce Street, 5 White Building
Philadelphia, PA 19104
Philadelphia, PA 19104
Education:
M.D.
Semmelweis University Medical School, Budapest, Hungary, 1989.
B.S. (Physical Therapy)
Medical Postgraduate University Medical College, 1989.
Permanent linkM.D.
Semmelweis University Medical School, Budapest, Hungary, 1989.
B.S. (Physical Therapy)
Medical Postgraduate University Medical College, 1989.
Description of Clinical Expertise
Undiagnosed Diseases Network, National Institutes of Health Common FundSelected Publications
Courtwright AM, Diamond JM, Sandorfi N, Goldberg HJ. : The Impact of Donor-Recipient Human Leukocyte Antigen Matching on Bronchiolitis Obliterans-Free Survival Among Lung Transplant Recipients With Connective Tissue Diseases. Clin Transplant. 38((8)), Aug 2024.Luebker S, Frech T, Assassi S, Skaug B, Gordon JK, Lakin K, Bernstein EJ, Luo Y, Steen VD, Shah AA, Hummers LK, Richardson C, Moore DF, Khanna D, Castelino FV, Chung L, Kapoor P, Hant FN, Shanmugam VK, VanBuren JM, Alvey J, Harding M, Shah A, Makol A, Lebiedz-Odrobina D, Thomas JK, Volkmann ER, Molitor JA, Sandorfi N: CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization. Rheumatology (Oxford) 20:kead176, Oct 2023
Spiera R, Kuwana M, Khanna D, Hummers L, Frech TM, Stevens W, Matucci-Cerinic M, Kafaja S, Distler O, Jun JB, Levy Y, Leszcyzński P, Gordon J, Steen V, Lee EB, Jankowski T, Litinsky I, Chung L, Hsu V, Mayes M, Sandorfi N, Simms RW, Finzel S, de Vries-Bouwstra J, Constantine S, Dgetluck N, Dinh Q, Bloom BJ, Furst DE, White B, Denton CP; RESOLVE-1 Study Group: Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis. Arthritis Rheumatol. 75((9)), Sep 2023
Morrisroe K, Sandorfi N, Barron M: Health Care Utilization: What Is the Cost of Caring for Scleroderma? Rheum Dis Clin North Am. 49((2)): 359-375, May 2023
Luebker S, Frech TM, Assassi S, Gordon JK, Bernstein EJ, Steen VD, Shah AA, Hummers LK, Richardson C, Khanna D, Castelino FV, Chung L, Hant FN, Shanmugam VK, VanBuren JM, Alvey J, Harding M, Sandorfi N.: The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation. Clin Exp Rheumatol. 41((8)), Aug 2023.
Bernstein EJ, Assassi S, Castelino FV, Chung L, Correia C, Evnin LB, Frech TM, Gordon JK, Skaug BA, Hant FN, Hummers LK, Sandorfi N, Shah AA, Shanmugam VK, Steen VD, Khanna D.: Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States. ACR Open Rheumatol. Apr 2022 Notes: Epub ahead of print.
Castelino FV, VanBuren JM, Startup E, Assassi S, Bernstein EJ, Chung L, Correia C, Evnin LB, Frech TM, Gordon JK, Hant FN, Hummers LK, Khanna D, Sandorfi N, Shah AA, Shanmugam VK, Steen V.: Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registry. Int J Rheum Dis. 25(2): 163-174, Feb 2022.
Luebker S, Frech T, Assassi A, Gordon J, Bernstein E, Steen V, Shah A, Hummers L, Richardson C, Khanna D, Castelino F, Chung L, Hant F, Shanmugam V, VanBuren J, Alvey J, Harding M, Evnin L, Sandorfi N: The Collaborative National Quality and Efficacy Registry for Scleroderma: Association of Medication Use on Gastrointestinal Tract Symptoms in Early Disease. American College of Rheumatology Convergence Meeting 2022.
Luebker S, Frech T, Assassi A, Gordon J, Bernstein E, Steen V, Shah A, Hummers L, Richardson C, Khanna D, Castelino F, Chung L, Hant F, Shanmugam V, VanBuren J, Alvey J, Harding M, Evnin L, Sandorfi N: The Collaborative National Quality and Efficacy Registry for Scleroderma: Association of Resource Utilization and Gastrointestinal Tract Symptoms in Early Disease. American College of Rheumatology Convergence Meeting 2022.
Bosso A, Assassi S, Frech T, Gordon J, Bernstein E, Richardson C, Sandorfi N, Hummers L, Shah A, Khanna D, Chung L, Castelino1 F, Hant F, Shanmugam V, VanBuren J, Larkin A, Evnin L, Steen V: Autoantibodies in Patients with Early Systemic Sclerosis in the Collaborative National Quality and Efficacy Registry. American College of Rheumatology Convergence Meeting 2022.